Cell Signaling Technology
Cell Signaling Technology is a U.S. manufacturer of polyclonal and monoclonal antibodies for basic research, which are distributed worldwide. The product focus is in the area of post-translational modifications of proteins and signal transduction and va phospho -specific antibodies.
History
Michael J. Comb from Detroit, born in 1927, studied at Wayne State University, Michigan, and received his Ph.D. in epidemiology. Between 1961 and 1971 he held various positions at Harvard Medical School before he left the academic career and in 1974 the company New England Biolabs founded. This company with about 150 employees, among others, Nobel Laureate Richard John Roberts is known for its restriction enzymes which are mainly used in basic research use. 1999, the working group signal transduction by Michael J. Comb as an independent company Cell Signaling Technology, Inc. was spun off ( CST).
Since 2007, the company also maintains the website PhosphoSitePlus which emerged from a financially supported by NIH project. This website offers a wealth of information on post-translational protein modifications for scientists worldwide.
In an online survey in 2011 by Frost & Sullivan with over 1100 readers of The Scientist CST reached by all antibody producers the best assessment.
The online platform Labome indicates that in 2012 approximately 20% of 10100 examined scientific publications had used products from the CST.
Locations
The company's headquarters is located since 2005 in Danvers (Massachusetts ) and Boston, USA. The company has distribution offices since 2008 in Tokyo (Japan ), 2009 in Shanghai (China) and Leiden ( NL).
Competitor
- BD Biosciences
- Covance Research Products
- EBioscience
- Life Technologies
- Merck Millipore
- Miltenyi Biotec
- RnD Systems
- Santa Cruz Biotechnology
- Sigma Aldrich
- Thermo Fisher Scientific
- Synaptic Systems